医微客 - 【2018ASH抢先看】大会召开在即！中国好声音即将唱响！

【2018ASH抢先看】大会召开在即！中国好声音即将唱响！

临床医学

1970-01-01

1818 0

整理：肿瘤资讯

来源：肿瘤资讯

2018年12月1-4日，第60届美国血液学年会（ASH）将于美国·圣地亚哥隆重召开。每年的ASH无疑是众咖齐聚、精彩纷呈。随着中国肿瘤医学的发展，越来越多的中国学者相继登上这个顶级盛会的舞台。今年，将有哪些“中国声音”入选ASH口头报告呢？跟随小编一起来看看吧！

当地时间：12月1日

72 Myeloid-Derived Suppressor Cells (HLA-DR-/lowCD16-CD33+) Expanded By Granulocyte Colony-Stimulating Factor Can Prevent Acute Graft-Versus-Host Disease in Humanized Mouse and Patients Following HSCT

讲者：北京大学血液学研究所王柯

时间：12月1日 8:45 AM

地点：Grand Hall B (Manchester Grand Hyatt San Diego)

链接：https://ash.confex.com/ash/2018/webprogram/Paper114291.html

76 Endothelial O-Glycoproteins Cooperate with Platelet CLEC-2 Signaling to Maintain Cerebrovascular Integrity during Mouse Development

讲者：苏州大学附属第一医院傅建新

时间：12月1日 10:15 AM

地点：Room 28D (San Diego Convention Center)

链接：https://ash.confex.com/ash/2018/webprogram/Paper118929.html

148 Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial

讲者：北京大学肿瘤医院宋玉琴

时间：12月1日 12:45 PM

地点：Pacific Ballroom 20 (Marriott Marquis San Diego Marina)

链接：https://ash.confex.com/ash/2018/webprogram/Paper117956.html

212 The Novel Berbamine Derivative, Cbbm, Downregulates c-Myc to Block Diffuse Large B-Cell Lymphoma Cell Maintenance

讲者：浙江大学医学院附属邵逸夫医院张蕾

时间：12月1日 2:15 PM

地点：Room 7B (San Diego Convention Center)

链接：https://ash.confex.com/ash/2018/webprogram/Paper112006.html

192 High Expression of NEK2 Mediated By p53 Contributes to Progression and Relapse of Multiple Myeloma

讲者：中国医学科学院北京协和医学院血液学研究所周文

时间：12月1日 3:15 PM

地点：Grand Ballroom 7 (Marriott Marquis San Diego Marina)

链接：https://ash.confex.com/ash/2018/webprogram/Paper116155.html

199 A Novel Recombinant Human Thrombopoietin Therapy for Promoting Platelet Engraftment in Haematological Malignancies after Single Umbilical Cord Blood Transplantation: A Prospective Randomized Controlled Trial

讲者：中国科技大学附属第一医院朱小玉

时间：12月1日 2:00 PM

地点：Grand Hall B (Manchester Grand Hyatt San Diego)

链接：https://ash.confex.com/ash/2018/webprogram/Paper118195.html

当地时间：12月2日

277 A Feasibility and Safety Study of CD19 and CD22 Chimeric Antigen Receptors-Modified T Cell Cocktail for Therapy of B Cell Acute Lymphoblastic Leukemia

讲者：陆道培医院陆佩华

时间：12月2日7:30 AM

地点：Ballroom 20D (San Diego Convention Center)

链接：https://ash.confex.com/ash/2018/webprogram/Paper114415.html

280 Efficacy and Safety of CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphocytic Leukemia (B-cell ALL) in a Large Cohort Including Patients with Extramedullary Disease(EMD), High Leukemia Burden, BCR-ABL (+) Mutation,TP53 Mutation, and Post-Transplant Relapse

讲者：陆道培医院张弦

时间：12月2日 8:15 AM

地点：Ballroom 20D (San Diego Convention Center)

链接：https://ash.confex.com/ash/2018/webprogram/Paper115642.html

360 Poor NKG2C+ Adaptive NK Cell Recovery at Early Stage after Allo-HSCT Increased the Occurrence of Refractory Cytomegalovirus Infection

讲者：北京大学血液学研究所余星星

时间：12月2日10:45 AM

地点：Grand Hall A (Manchester Grand Hyatt San Diego)

链接：https://ash.confex.com/ash/2018/webprogram/Paper115772.html

当地时间：12月3日

682 Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study

讲者：北京大学肿瘤医院宋玉琴

时间：12月3日11:15 AM

地点：Room 6F (San Diego Convention Center)

链接：https://ash.confex.com/ash/2018/webprogram/Paper117848.html

727 First-Line Therapy with Donor Derived HCMV-Specific T Cells Reduce Persistent HCMV Infection after Allogenic Stem Cell Transplantation

讲者：北京大学血液学研究所赵翔宇

时间：12月3日 2:45 PM

地点：Room 8 (San Diego Convention Center)

链接：https://ash.confex.com/ash/2018/webprogram/Paper113923.html

791 Safety and Efficacy of HQP1351, a 3rd Generation Oral BCR-ABL Inhibitor in Patients with Tyrosine Kinase Inhibitor -Resistant Chronic Myelogenous Leukemia: Preliminary Results of Phase I Study

讲者：北京大学血液学研究所江倩

时间：12月3日 3:45 PM

地点：Room 6E (San Diego Convention Center)

链接：https://ash.confex.com/ash/2018/webprogram/Paper119142.html

901 First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial

讲者：成都总医院造血干细胞移植中心刘芳

时间：12月3日 4:30 PM

地点：Seaport Ballroom F (Manchester Grand Hyatt San Diego)

链接：https://ash.confex.com/ash/2018/webprogram/Paper110579.html

955 Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

讲者：西安交大附属二院赵万红

时间：12月3日4:30 PM

地点：Ballroom 20A (San Diego Convention Center)

链接：https://ash.confex.com/ash/2018/webprogram/Paper110548.html

956 Durable Remission Achieved from Bcma-Directed CAR-T Therapy Against Relapsed or Refractory Multiple Myeloma

讲者：上海恒润达生生物科技有限公司 刘雅容

时间：12月3日 4:45 PM

地点：Ballroom 20A (San Diego Convention Center)

链接：https://ash.confex.com/ash/2018/webprogram/Paper112786.html

960 Low Dose of Human scFv-Derived BCMA-Targeted CAR-T Cells Achieved Fast Response and High Complete Remission in Patients with Relapsed/Refractory Multiple Myeloma

讲者：温州医科大学附属第一医院江松福

时间：12月3日 5:45 PM

地点：Ballroom 20A (San Diego Convention Center)

链接：https://ash.confex.com/ash/2018/webprogram/Paper113220.html

1009 Tandom Autologous Transplantation and Combined Infusion of CD19 and Bcma-Specific Chimeric Antigen Receptor T Cells for High Risk MM: Initial Safety and Efficacy Report from a Clinical Pilot Study

讲者：苏州大学附属第一医院傅琤琤

时间：12月3日 6:15 PM

地点：Ballroom 20D (San Diego Convention Center)

链接：https://ash.confex.com/ash/2018/webprogram/Paper117964.html

1013 T Cells Expressing Anti B-Cell Maturation Antigen Chimeric Antigen Receptors for Plasma Cell Malignancies

讲者：华中科技大学同济医学院同济医院李春蕊

时间：12月3日 7:15 PM

地点：Ballroom 20D (San Diego Convention Center)

链接：https://ash.confex.com/ash/2018/webprogram/Paper116898.html

欢迎大家持续追踪后续报道。如有遗漏，敬请留言补充！

责任编辑：肿瘤资讯-Amiee

欲了解更多血液肿瘤、淋巴瘤相关资讯，与全国各地血液肿瘤、淋巴瘤医生交流与讨论，请扫描以下二维码，添加肿瘤资讯-娜小编，备注“血液肿瘤”！